Quick Answer
Anixa Biosciences Inc reported Net Income Loss of -$10.93 million for the year ending 2025.
- Anixa Biosciences Inc showed an increase of +13.0% in Net Income Loss from 2024 to 2025.
- This data is from Anixa Biosciences Inc's annual report (Form 10-K), filed with the SEC on January 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), Anixa Biosciences Inc's Net Income Loss has declined by 111.1%.
- Historical annual values: Fiscal year 2025: -$10.93 million | Fiscal year 2024: -$12.55 million | Fiscal year 2023: -$9.81 million | Fiscal year 2022: -$13.60 million | Fiscal year 2021: -$12.95 million | Fiscal year 2020: -$10.02 million | Fiscal year 2019: -$11.65 million | Fiscal year 2018: -$14.00 million | Fiscal year 2017: -$5.01 million | Fiscal year 2016: -$5.02 million | Fiscal year 2015: -$1.38 million | Fiscal year 2014: -$9.61 million | Fiscal year 2013: -$10.08 million | Fiscal year 2012: -$4.25 million | Fiscal year 2011: -$7.38 million | Fiscal year 2010: -$5.18 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: